NCT03925324View on ClinicalTrials.gov

Serial Infusions of Allogeneic Mesenchymal Stem Cells in Cardiomyopathy Patients With Left Ventricular Assist Device

PHASE2TerminatedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

May 3, 2019

Primary Completion Date

August 16, 2021

Study Completion Date

August 16, 2021

Conditions
Ischemic Heart DiseaseNon-ischemic Cardiomyopathy
Interventions
BIOLOGICAL

Human Allogeneic Mesenchymal Bone Marrow Cells (aMBMC)

Allogeneic Mesenchymal Bone Marrow Cells (aMBMC) 1.5 million cells/kg

OTHER

Placebo

1.5 mL/kg Lactated Ringer's Solution

Trial Locations (1)

20010

MedStar Washington Hospital Center, Washington D.C.

Sponsors
All Listed Sponsors
lead

Medstar Health Research Institute

OTHER